Anti-LAG3/CD223 Antibody (Ieramilimab)
Catalog No.
F1190
Anti-LAG3/CD223 Antibody (Ieramilimab)
Featured Products
Ieramilimab (Anti-LAG3/CD223) is a humanized IgG4 monoclonal antibody targeting LAG-3. It has anti-tumor activity and can be used to treat advanced malignancies, MW: 146.78 KD.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.78 kDa
Dry ice
2137049-37-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IMP701, LAG525, NVS250617
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P18627
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
LAG3 / CD223
Please avoid freeze-thaw cycles.